Global Gastric Cancer Diagnostics Market Growth (Status and Outlook) 2026-2032
The global Gastric Cancer Diagnostics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gastric Cancer Diagnostics Industry Forecast” looks at past sales and reviews total world Gastric Cancer Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Gastric Cancer Diagnostics sales for 2026 through 2032. With Gastric Cancer Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastric Cancer Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Gastric Cancer Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gastric Cancer Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastric Cancer Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastric Cancer Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastric Cancer Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastric Cancer Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gastric Cancer Diagnostics Industry Forecast” looks at past sales and reviews total world Gastric Cancer Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Gastric Cancer Diagnostics sales for 2026 through 2032. With Gastric Cancer Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastric Cancer Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Gastric Cancer Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gastric Cancer Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastric Cancer Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastric Cancer Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastric Cancer Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastric Cancer Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Instrument
- Reagent Consumables
- Service
- Male
- Female
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Myriad Genetics
- ACON Laboratories
- Teco Diagnostics
- Vela Diagnostics
- Abbott, AdvaCare Pharma
- Fujirebio (An H.U. Group company)
- Thermo Fisher Scientific
- F. Hoffmann-La Roche
- General Electric
- Agilent Technologies
- Endofotonics
- Biohit Oyj
- BIOCEPT
- FOUNDATION MEDICINE
- DiaSorin S.p.A
- Paragon Genomics
- BIOM?RIEUX
- QIAGEN
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastric Cancer Diagnostics Market Size (2021-2032)
2.1.2 Gastric Cancer Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Gastric Cancer Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Gastric Cancer Diagnostics Segment by Type
2.2.1 Instrument
2.2.2 Reagent Consumables
2.2.3 Service
2.2.4 Gastric Cancer Diagnostics Market Size by Type
2.2.4.1 Gastric Cancer Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Gastric Cancer Diagnostics Segment by Application
2.3.1 Male
2.3.2 Female
2.3.3 Gastric Cancer Diagnostics Market Size by Application
2.3.3.1 Gastric Cancer Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
3 GASTRIC CANCER DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Gastric Cancer Diagnostics Market Size Market Share by Player
3.1.1 Global Gastric Cancer Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Gastric Cancer Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Gastric Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTRIC CANCER DIAGNOSTICS BY REGION
4.1 Gastric Cancer Diagnostics Market Size by Region (2021-2026)
4.2 Global Gastric Cancer Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Gastric Cancer Diagnostics Market Size Growth (2021-2026)
4.4 APAC Gastric Cancer Diagnostics Market Size Growth (2021-2026)
4.5 Europe Gastric Cancer Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Gastric Cancer Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Gastric Cancer Diagnostics Market Size by Country (2021-2026)
5.2 Americas Gastric Cancer Diagnostics Market Size by Type (2021-2026)
5.3 Americas Gastric Cancer Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastric Cancer Diagnostics Market Size by Region (2021-2026)
6.2 APAC Gastric Cancer Diagnostics Market Size by Type (2021-2026)
6.3 APAC Gastric Cancer Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastric Cancer Diagnostics Market Size by Country (2021-2026)
7.2 Europe Gastric Cancer Diagnostics Market Size by Type (2021-2026)
7.3 Europe Gastric Cancer Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastric Cancer Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Gastric Cancer Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Gastric Cancer Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTRIC CANCER DIAGNOSTICS MARKET FORECAST
10.1 Global Gastric Cancer Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Gastric Cancer Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Gastric Cancer Diagnostics Forecast
10.1.3 APAC Gastric Cancer Diagnostics Forecast
10.1.4 Europe Gastric Cancer Diagnostics Forecast
10.1.5 Middle East & Africa Gastric Cancer Diagnostics Forecast
10.2 Americas Gastric Cancer Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Gastric Cancer Diagnostics Forecast
10.2.2 Canada Market Gastric Cancer Diagnostics Forecast
10.2.3 Mexico Market Gastric Cancer Diagnostics Forecast
10.2.4 Brazil Market Gastric Cancer Diagnostics Forecast
10.3 APAC Gastric Cancer Diagnostics Forecast by Region (2027-2032)
10.3.1 China Gastric Cancer Diagnostics Market Forecast
10.3.2 Japan Market Gastric Cancer Diagnostics Forecast
10.3.3 Korea Market Gastric Cancer Diagnostics Forecast
10.3.4 Southeast Asia Market Gastric Cancer Diagnostics Forecast
10.3.5 India Market Gastric Cancer Diagnostics Forecast
10.3.6 Australia Market Gastric Cancer Diagnostics Forecast
10.4 Europe Gastric Cancer Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Gastric Cancer Diagnostics Forecast
10.4.2 France Market Gastric Cancer Diagnostics Forecast
10.4.3 UK Market Gastric Cancer Diagnostics Forecast
10.4.4 Italy Market Gastric Cancer Diagnostics Forecast
10.4.5 Russia Market Gastric Cancer Diagnostics Forecast
10.5 Middle East & Africa Gastric Cancer Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Gastric Cancer Diagnostics Forecast
10.5.2 South Africa Market Gastric Cancer Diagnostics Forecast
10.5.3 Israel Market Gastric Cancer Diagnostics Forecast
10.5.4 Turkey Market Gastric Cancer Diagnostics Forecast
10.6 Global Gastric Cancer Diagnostics Forecast by Type (2027-2032)
10.7 Global Gastric Cancer Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Gastric Cancer Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Information
11.1.2 Myriad Genetics Gastric Cancer Diagnostics Product Offered
11.1.3 Myriad Genetics Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Myriad Genetics Main Business Overview
11.1.5 Myriad Genetics Latest Developments
11.2 ACON Laboratories
11.2.1 ACON Laboratories Company Information
11.2.2 ACON Laboratories Gastric Cancer Diagnostics Product Offered
11.2.3 ACON Laboratories Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 ACON Laboratories Main Business Overview
11.2.5 ACON Laboratories Latest Developments
11.3 Teco Diagnostics
11.3.1 Teco Diagnostics Company Information
11.3.2 Teco Diagnostics Gastric Cancer Diagnostics Product Offered
11.3.3 Teco Diagnostics Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Teco Diagnostics Main Business Overview
11.3.5 Teco Diagnostics Latest Developments
11.4 Vela Diagnostics
11.4.1 Vela Diagnostics Company Information
11.4.2 Vela Diagnostics Gastric Cancer Diagnostics Product Offered
11.4.3 Vela Diagnostics Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Vela Diagnostics Main Business Overview
11.4.5 Vela Diagnostics Latest Developments
11.5 Abbott, AdvaCare Pharma
11.5.1 Abbott, AdvaCare Pharma Company Information
11.5.2 Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Product Offered
11.5.3 Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Abbott, AdvaCare Pharma Main Business Overview
11.5.5 Abbott, AdvaCare Pharma Latest Developments
11.6 Fujirebio (An H.U. Group company)
11.6.1 Fujirebio (An H.U. Group company) Company Information
11.6.2 Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Product Offered
11.6.3 Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fujirebio (An H.U. Group company) Main Business Overview
11.6.5 Fujirebio (An H.U. Group company) Latest Developments
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Information
11.7.2 Thermo Fisher Scientific Gastric Cancer Diagnostics Product Offered
11.7.3 Thermo Fisher Scientific Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Thermo Fisher Scientific Main Business Overview
11.7.5 Thermo Fisher Scientific Latest Developments
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Information
11.8.2 F. Hoffmann-La Roche Gastric Cancer Diagnostics Product Offered
11.8.3 F. Hoffmann-La Roche Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 F. Hoffmann-La Roche Main Business Overview
11.8.5 F. Hoffmann-La Roche Latest Developments
11.9 General Electric
11.9.1 General Electric Company Information
11.9.2 General Electric Gastric Cancer Diagnostics Product Offered
11.9.3 General Electric Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 General Electric Main Business Overview
11.9.5 General Electric Latest Developments
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Information
11.10.2 Agilent Technologies Gastric Cancer Diagnostics Product Offered
11.10.3 Agilent Technologies Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Agilent Technologies Main Business Overview
11.10.5 Agilent Technologies Latest Developments
11.11 Endofotonics
11.11.1 Endofotonics Company Information
11.11.2 Endofotonics Gastric Cancer Diagnostics Product Offered
11.11.3 Endofotonics Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Endofotonics Main Business Overview
11.11.5 Endofotonics Latest Developments
11.12 Biohit Oyj
11.12.1 Biohit Oyj Company Information
11.12.2 Biohit Oyj Gastric Cancer Diagnostics Product Offered
11.12.3 Biohit Oyj Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Biohit Oyj Main Business Overview
11.12.5 Biohit Oyj Latest Developments
11.13 BIOCEPT
11.13.1 BIOCEPT Company Information
11.13.2 BIOCEPT Gastric Cancer Diagnostics Product Offered
11.13.3 BIOCEPT Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 BIOCEPT Main Business Overview
11.13.5 BIOCEPT Latest Developments
11.14 FOUNDATION MEDICINE
11.14.1 FOUNDATION MEDICINE Company Information
11.14.2 FOUNDATION MEDICINE Gastric Cancer Diagnostics Product Offered
11.14.3 FOUNDATION MEDICINE Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 FOUNDATION MEDICINE Main Business Overview
11.14.5 FOUNDATION MEDICINE Latest Developments
11.15 DiaSorin S.p.A
11.15.1 DiaSorin S.p.A Company Information
11.15.2 DiaSorin S.p.A Gastric Cancer Diagnostics Product Offered
11.15.3 DiaSorin S.p.A Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 DiaSorin S.p.A Main Business Overview
11.15.5 DiaSorin S.p.A Latest Developments
11.16 Paragon Genomics
11.16.1 Paragon Genomics Company Information
11.16.2 Paragon Genomics Gastric Cancer Diagnostics Product Offered
11.16.3 Paragon Genomics Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Paragon Genomics Main Business Overview
11.16.5 Paragon Genomics Latest Developments
11.17 BIOM?RIEUX
11.17.1 BIOM?RIEUX Company Information
11.17.2 BIOM?RIEUX Gastric Cancer Diagnostics Product Offered
11.17.3 BIOM?RIEUX Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 BIOM?RIEUX Main Business Overview
11.17.5 BIOM?RIEUX Latest Developments
11.18 QIAGEN
11.18.1 QIAGEN Company Information
11.18.2 QIAGEN Gastric Cancer Diagnostics Product Offered
11.18.3 QIAGEN Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 QIAGEN Main Business Overview
11.18.5 QIAGEN Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastric Cancer Diagnostics Market Size (2021-2032)
2.1.2 Gastric Cancer Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Gastric Cancer Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Gastric Cancer Diagnostics Segment by Type
2.2.1 Instrument
2.2.2 Reagent Consumables
2.2.3 Service
2.2.4 Gastric Cancer Diagnostics Market Size by Type
2.2.4.1 Gastric Cancer Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Gastric Cancer Diagnostics Segment by Application
2.3.1 Male
2.3.2 Female
2.3.3 Gastric Cancer Diagnostics Market Size by Application
2.3.3.1 Gastric Cancer Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
3 GASTRIC CANCER DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Gastric Cancer Diagnostics Market Size Market Share by Player
3.1.1 Global Gastric Cancer Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Gastric Cancer Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Gastric Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTRIC CANCER DIAGNOSTICS BY REGION
4.1 Gastric Cancer Diagnostics Market Size by Region (2021-2026)
4.2 Global Gastric Cancer Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Gastric Cancer Diagnostics Market Size Growth (2021-2026)
4.4 APAC Gastric Cancer Diagnostics Market Size Growth (2021-2026)
4.5 Europe Gastric Cancer Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Gastric Cancer Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Gastric Cancer Diagnostics Market Size by Country (2021-2026)
5.2 Americas Gastric Cancer Diagnostics Market Size by Type (2021-2026)
5.3 Americas Gastric Cancer Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastric Cancer Diagnostics Market Size by Region (2021-2026)
6.2 APAC Gastric Cancer Diagnostics Market Size by Type (2021-2026)
6.3 APAC Gastric Cancer Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastric Cancer Diagnostics Market Size by Country (2021-2026)
7.2 Europe Gastric Cancer Diagnostics Market Size by Type (2021-2026)
7.3 Europe Gastric Cancer Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastric Cancer Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Gastric Cancer Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Gastric Cancer Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTRIC CANCER DIAGNOSTICS MARKET FORECAST
10.1 Global Gastric Cancer Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Gastric Cancer Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Gastric Cancer Diagnostics Forecast
10.1.3 APAC Gastric Cancer Diagnostics Forecast
10.1.4 Europe Gastric Cancer Diagnostics Forecast
10.1.5 Middle East & Africa Gastric Cancer Diagnostics Forecast
10.2 Americas Gastric Cancer Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Gastric Cancer Diagnostics Forecast
10.2.2 Canada Market Gastric Cancer Diagnostics Forecast
10.2.3 Mexico Market Gastric Cancer Diagnostics Forecast
10.2.4 Brazil Market Gastric Cancer Diagnostics Forecast
10.3 APAC Gastric Cancer Diagnostics Forecast by Region (2027-2032)
10.3.1 China Gastric Cancer Diagnostics Market Forecast
10.3.2 Japan Market Gastric Cancer Diagnostics Forecast
10.3.3 Korea Market Gastric Cancer Diagnostics Forecast
10.3.4 Southeast Asia Market Gastric Cancer Diagnostics Forecast
10.3.5 India Market Gastric Cancer Diagnostics Forecast
10.3.6 Australia Market Gastric Cancer Diagnostics Forecast
10.4 Europe Gastric Cancer Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Gastric Cancer Diagnostics Forecast
10.4.2 France Market Gastric Cancer Diagnostics Forecast
10.4.3 UK Market Gastric Cancer Diagnostics Forecast
10.4.4 Italy Market Gastric Cancer Diagnostics Forecast
10.4.5 Russia Market Gastric Cancer Diagnostics Forecast
10.5 Middle East & Africa Gastric Cancer Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Gastric Cancer Diagnostics Forecast
10.5.2 South Africa Market Gastric Cancer Diagnostics Forecast
10.5.3 Israel Market Gastric Cancer Diagnostics Forecast
10.5.4 Turkey Market Gastric Cancer Diagnostics Forecast
10.6 Global Gastric Cancer Diagnostics Forecast by Type (2027-2032)
10.7 Global Gastric Cancer Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Gastric Cancer Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Information
11.1.2 Myriad Genetics Gastric Cancer Diagnostics Product Offered
11.1.3 Myriad Genetics Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Myriad Genetics Main Business Overview
11.1.5 Myriad Genetics Latest Developments
11.2 ACON Laboratories
11.2.1 ACON Laboratories Company Information
11.2.2 ACON Laboratories Gastric Cancer Diagnostics Product Offered
11.2.3 ACON Laboratories Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 ACON Laboratories Main Business Overview
11.2.5 ACON Laboratories Latest Developments
11.3 Teco Diagnostics
11.3.1 Teco Diagnostics Company Information
11.3.2 Teco Diagnostics Gastric Cancer Diagnostics Product Offered
11.3.3 Teco Diagnostics Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Teco Diagnostics Main Business Overview
11.3.5 Teco Diagnostics Latest Developments
11.4 Vela Diagnostics
11.4.1 Vela Diagnostics Company Information
11.4.2 Vela Diagnostics Gastric Cancer Diagnostics Product Offered
11.4.3 Vela Diagnostics Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Vela Diagnostics Main Business Overview
11.4.5 Vela Diagnostics Latest Developments
11.5 Abbott, AdvaCare Pharma
11.5.1 Abbott, AdvaCare Pharma Company Information
11.5.2 Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Product Offered
11.5.3 Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Abbott, AdvaCare Pharma Main Business Overview
11.5.5 Abbott, AdvaCare Pharma Latest Developments
11.6 Fujirebio (An H.U. Group company)
11.6.1 Fujirebio (An H.U. Group company) Company Information
11.6.2 Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Product Offered
11.6.3 Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fujirebio (An H.U. Group company) Main Business Overview
11.6.5 Fujirebio (An H.U. Group company) Latest Developments
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Information
11.7.2 Thermo Fisher Scientific Gastric Cancer Diagnostics Product Offered
11.7.3 Thermo Fisher Scientific Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Thermo Fisher Scientific Main Business Overview
11.7.5 Thermo Fisher Scientific Latest Developments
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Information
11.8.2 F. Hoffmann-La Roche Gastric Cancer Diagnostics Product Offered
11.8.3 F. Hoffmann-La Roche Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 F. Hoffmann-La Roche Main Business Overview
11.8.5 F. Hoffmann-La Roche Latest Developments
11.9 General Electric
11.9.1 General Electric Company Information
11.9.2 General Electric Gastric Cancer Diagnostics Product Offered
11.9.3 General Electric Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 General Electric Main Business Overview
11.9.5 General Electric Latest Developments
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Information
11.10.2 Agilent Technologies Gastric Cancer Diagnostics Product Offered
11.10.3 Agilent Technologies Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Agilent Technologies Main Business Overview
11.10.5 Agilent Technologies Latest Developments
11.11 Endofotonics
11.11.1 Endofotonics Company Information
11.11.2 Endofotonics Gastric Cancer Diagnostics Product Offered
11.11.3 Endofotonics Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Endofotonics Main Business Overview
11.11.5 Endofotonics Latest Developments
11.12 Biohit Oyj
11.12.1 Biohit Oyj Company Information
11.12.2 Biohit Oyj Gastric Cancer Diagnostics Product Offered
11.12.3 Biohit Oyj Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Biohit Oyj Main Business Overview
11.12.5 Biohit Oyj Latest Developments
11.13 BIOCEPT
11.13.1 BIOCEPT Company Information
11.13.2 BIOCEPT Gastric Cancer Diagnostics Product Offered
11.13.3 BIOCEPT Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 BIOCEPT Main Business Overview
11.13.5 BIOCEPT Latest Developments
11.14 FOUNDATION MEDICINE
11.14.1 FOUNDATION MEDICINE Company Information
11.14.2 FOUNDATION MEDICINE Gastric Cancer Diagnostics Product Offered
11.14.3 FOUNDATION MEDICINE Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 FOUNDATION MEDICINE Main Business Overview
11.14.5 FOUNDATION MEDICINE Latest Developments
11.15 DiaSorin S.p.A
11.15.1 DiaSorin S.p.A Company Information
11.15.2 DiaSorin S.p.A Gastric Cancer Diagnostics Product Offered
11.15.3 DiaSorin S.p.A Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 DiaSorin S.p.A Main Business Overview
11.15.5 DiaSorin S.p.A Latest Developments
11.16 Paragon Genomics
11.16.1 Paragon Genomics Company Information
11.16.2 Paragon Genomics Gastric Cancer Diagnostics Product Offered
11.16.3 Paragon Genomics Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Paragon Genomics Main Business Overview
11.16.5 Paragon Genomics Latest Developments
11.17 BIOM?RIEUX
11.17.1 BIOM?RIEUX Company Information
11.17.2 BIOM?RIEUX Gastric Cancer Diagnostics Product Offered
11.17.3 BIOM?RIEUX Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 BIOM?RIEUX Main Business Overview
11.17.5 BIOM?RIEUX Latest Developments
11.18 QIAGEN
11.18.1 QIAGEN Company Information
11.18.2 QIAGEN Gastric Cancer Diagnostics Product Offered
11.18.3 QIAGEN Gastric Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 QIAGEN Main Business Overview
11.18.5 QIAGEN Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gastric Cancer Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Gastric Cancer Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Instrument
Table 4. Major Players of Reagent Consumables
Table 5. Major Players of Service
Table 6. Gastric Cancer Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Gastric Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Table 9. Gastric Cancer Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Gastric Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Table 12. Global Gastric Cancer Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Gastric Cancer Diagnostics Revenue Market Share by Player (2021-2026)
Table 14. Gastric Cancer Diagnostics Key Players Head office and Products Offered
Table 15. Gastric Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gastric Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Gastric Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Table 20. Global Gastric Cancer Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Gastric Cancer Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Gastric Cancer Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Gastric Cancer Diagnostics Market Size Market Share by Country (2021-2026)
Table 24. Americas Gastric Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Table 26. Americas Gastric Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Table 28. APAC Gastric Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Gastric Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Table 30. APAC Gastric Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Gastric Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Gastric Cancer Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Gastric Cancer Diagnostics Market Size Market Share by Country (2021-2026)
Table 34. Europe Gastric Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Gastric Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Gastric Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Gastric Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Gastric Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Gastric Cancer Diagnostics
Table 40. Key Market Challenges & Risks of Gastric Cancer Diagnostics
Table 41. Key Industry Trends of Gastric Cancer Diagnostics
Table 42. Global Gastric Cancer Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Gastric Cancer Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Gastric Cancer Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Gastric Cancer Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Myriad Genetics Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 47. Myriad Genetics Gastric Cancer Diagnostics Product Offered
Table 48. Myriad Genetics Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Myriad Genetics Main Business
Table 50. Myriad Genetics Latest Developments
Table 51. ACON Laboratories Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 52. ACON Laboratories Gastric Cancer Diagnostics Product Offered
Table 53. ACON Laboratories Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. ACON Laboratories Main Business
Table 55. ACON Laboratories Latest Developments
Table 56. Teco Diagnostics Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 57. Teco Diagnostics Gastric Cancer Diagnostics Product Offered
Table 58. Teco Diagnostics Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Teco Diagnostics Main Business
Table 60. Teco Diagnostics Latest Developments
Table 61. Vela Diagnostics Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 62. Vela Diagnostics Gastric Cancer Diagnostics Product Offered
Table 63. Vela Diagnostics Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Vela Diagnostics Main Business
Table 65. Vela Diagnostics Latest Developments
Table 66. Abbott, AdvaCare Pharma Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 67. Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Product Offered
Table 68. Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Abbott, AdvaCare Pharma Main Business
Table 70. Abbott, AdvaCare Pharma Latest Developments
Table 71. Fujirebio (An H.U. Group company) Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 72. Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Product Offered
Table 73. Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Fujirebio (An H.U. Group company) Main Business
Table 75. Fujirebio (An H.U. Group company) Latest Developments
Table 76. Thermo Fisher Scientific Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 77. Thermo Fisher Scientific Gastric Cancer Diagnostics Product Offered
Table 78. Thermo Fisher Scientific Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Thermo Fisher Scientific Main Business
Table 80. Thermo Fisher Scientific Latest Developments
Table 81. F. Hoffmann-La Roche Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 82. F. Hoffmann-La Roche Gastric Cancer Diagnostics Product Offered
Table 83. F. Hoffmann-La Roche Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. F. Hoffmann-La Roche Main Business
Table 85. F. Hoffmann-La Roche Latest Developments
Table 86. General Electric Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 87. General Electric Gastric Cancer Diagnostics Product Offered
Table 88. General Electric Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. General Electric Main Business
Table 90. General Electric Latest Developments
Table 91. Agilent Technologies Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 92. Agilent Technologies Gastric Cancer Diagnostics Product Offered
Table 93. Agilent Technologies Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Agilent Technologies Main Business
Table 95. Agilent Technologies Latest Developments
Table 96. Endofotonics Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 97. Endofotonics Gastric Cancer Diagnostics Product Offered
Table 98. Endofotonics Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Endofotonics Main Business
Table 100. Endofotonics Latest Developments
Table 101. Biohit Oyj Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 102. Biohit Oyj Gastric Cancer Diagnostics Product Offered
Table 103. Biohit Oyj Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Biohit Oyj Main Business
Table 105. Biohit Oyj Latest Developments
Table 106. BIOCEPT Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 107. BIOCEPT Gastric Cancer Diagnostics Product Offered
Table 108. BIOCEPT Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. BIOCEPT Main Business
Table 110. BIOCEPT Latest Developments
Table 111. FOUNDATION MEDICINE Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 112. FOUNDATION MEDICINE Gastric Cancer Diagnostics Product Offered
Table 113. FOUNDATION MEDICINE Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. FOUNDATION MEDICINE Main Business
Table 115. FOUNDATION MEDICINE Latest Developments
Table 116. DiaSorin S.p.A Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 117. DiaSorin S.p.A Gastric Cancer Diagnostics Product Offered
Table 118. DiaSorin S.p.A Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. DiaSorin S.p.A Main Business
Table 120. DiaSorin S.p.A Latest Developments
Table 121. Paragon Genomics Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 122. Paragon Genomics Gastric Cancer Diagnostics Product Offered
Table 123. Paragon Genomics Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Paragon Genomics Main Business
Table 125. Paragon Genomics Latest Developments
Table 126. BIOM?RIEUX Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 127. BIOM?RIEUX Gastric Cancer Diagnostics Product Offered
Table 128. BIOM?RIEUX Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. BIOM?RIEUX Main Business
Table 130. BIOM?RIEUX Latest Developments
Table 131. QIAGEN Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 132. QIAGEN Gastric Cancer Diagnostics Product Offered
Table 133. QIAGEN Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. QIAGEN Main Business
Table 135. QIAGEN Latest Developments
Table 1. Gastric Cancer Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Gastric Cancer Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Instrument
Table 4. Major Players of Reagent Consumables
Table 5. Major Players of Service
Table 6. Gastric Cancer Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Gastric Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Table 9. Gastric Cancer Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Gastric Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Table 12. Global Gastric Cancer Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Gastric Cancer Diagnostics Revenue Market Share by Player (2021-2026)
Table 14. Gastric Cancer Diagnostics Key Players Head office and Products Offered
Table 15. Gastric Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gastric Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Gastric Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Table 20. Global Gastric Cancer Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Gastric Cancer Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Gastric Cancer Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Gastric Cancer Diagnostics Market Size Market Share by Country (2021-2026)
Table 24. Americas Gastric Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Table 26. Americas Gastric Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Table 28. APAC Gastric Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Gastric Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Table 30. APAC Gastric Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Gastric Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Gastric Cancer Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Gastric Cancer Diagnostics Market Size Market Share by Country (2021-2026)
Table 34. Europe Gastric Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Gastric Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Gastric Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Gastric Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Gastric Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Gastric Cancer Diagnostics
Table 40. Key Market Challenges & Risks of Gastric Cancer Diagnostics
Table 41. Key Industry Trends of Gastric Cancer Diagnostics
Table 42. Global Gastric Cancer Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Gastric Cancer Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Gastric Cancer Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Gastric Cancer Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Myriad Genetics Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 47. Myriad Genetics Gastric Cancer Diagnostics Product Offered
Table 48. Myriad Genetics Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Myriad Genetics Main Business
Table 50. Myriad Genetics Latest Developments
Table 51. ACON Laboratories Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 52. ACON Laboratories Gastric Cancer Diagnostics Product Offered
Table 53. ACON Laboratories Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. ACON Laboratories Main Business
Table 55. ACON Laboratories Latest Developments
Table 56. Teco Diagnostics Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 57. Teco Diagnostics Gastric Cancer Diagnostics Product Offered
Table 58. Teco Diagnostics Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Teco Diagnostics Main Business
Table 60. Teco Diagnostics Latest Developments
Table 61. Vela Diagnostics Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 62. Vela Diagnostics Gastric Cancer Diagnostics Product Offered
Table 63. Vela Diagnostics Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Vela Diagnostics Main Business
Table 65. Vela Diagnostics Latest Developments
Table 66. Abbott, AdvaCare Pharma Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 67. Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Product Offered
Table 68. Abbott, AdvaCare Pharma Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Abbott, AdvaCare Pharma Main Business
Table 70. Abbott, AdvaCare Pharma Latest Developments
Table 71. Fujirebio (An H.U. Group company) Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 72. Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Product Offered
Table 73. Fujirebio (An H.U. Group company) Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Fujirebio (An H.U. Group company) Main Business
Table 75. Fujirebio (An H.U. Group company) Latest Developments
Table 76. Thermo Fisher Scientific Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 77. Thermo Fisher Scientific Gastric Cancer Diagnostics Product Offered
Table 78. Thermo Fisher Scientific Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Thermo Fisher Scientific Main Business
Table 80. Thermo Fisher Scientific Latest Developments
Table 81. F. Hoffmann-La Roche Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 82. F. Hoffmann-La Roche Gastric Cancer Diagnostics Product Offered
Table 83. F. Hoffmann-La Roche Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. F. Hoffmann-La Roche Main Business
Table 85. F. Hoffmann-La Roche Latest Developments
Table 86. General Electric Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 87. General Electric Gastric Cancer Diagnostics Product Offered
Table 88. General Electric Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. General Electric Main Business
Table 90. General Electric Latest Developments
Table 91. Agilent Technologies Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 92. Agilent Technologies Gastric Cancer Diagnostics Product Offered
Table 93. Agilent Technologies Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Agilent Technologies Main Business
Table 95. Agilent Technologies Latest Developments
Table 96. Endofotonics Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 97. Endofotonics Gastric Cancer Diagnostics Product Offered
Table 98. Endofotonics Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Endofotonics Main Business
Table 100. Endofotonics Latest Developments
Table 101. Biohit Oyj Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 102. Biohit Oyj Gastric Cancer Diagnostics Product Offered
Table 103. Biohit Oyj Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Biohit Oyj Main Business
Table 105. Biohit Oyj Latest Developments
Table 106. BIOCEPT Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 107. BIOCEPT Gastric Cancer Diagnostics Product Offered
Table 108. BIOCEPT Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. BIOCEPT Main Business
Table 110. BIOCEPT Latest Developments
Table 111. FOUNDATION MEDICINE Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 112. FOUNDATION MEDICINE Gastric Cancer Diagnostics Product Offered
Table 113. FOUNDATION MEDICINE Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. FOUNDATION MEDICINE Main Business
Table 115. FOUNDATION MEDICINE Latest Developments
Table 116. DiaSorin S.p.A Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 117. DiaSorin S.p.A Gastric Cancer Diagnostics Product Offered
Table 118. DiaSorin S.p.A Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. DiaSorin S.p.A Main Business
Table 120. DiaSorin S.p.A Latest Developments
Table 121. Paragon Genomics Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 122. Paragon Genomics Gastric Cancer Diagnostics Product Offered
Table 123. Paragon Genomics Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Paragon Genomics Main Business
Table 125. Paragon Genomics Latest Developments
Table 126. BIOM?RIEUX Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 127. BIOM?RIEUX Gastric Cancer Diagnostics Product Offered
Table 128. BIOM?RIEUX Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. BIOM?RIEUX Main Business
Table 130. BIOM?RIEUX Latest Developments
Table 131. QIAGEN Details, Company Type, Gastric Cancer Diagnostics Area Served and Its Competitors
Table 132. QIAGEN Gastric Cancer Diagnostics Product Offered
Table 133. QIAGEN Gastric Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. QIAGEN Main Business
Table 135. QIAGEN Latest Developments
LIST OF FIGURES
Figure 1. Gastric Cancer Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastric Cancer Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Gastric Cancer Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Gastric Cancer Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Gastric Cancer Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Gastric Cancer Diagnostics Market Size Market Share by Type in 2025
Figure 10. Gastric Cancer Diagnostics in Male
Figure 11. Global Gastric Cancer Diagnostics Market: Male (2021-2026) & ($ millions)
Figure 12. Gastric Cancer Diagnostics in Female
Figure 13. Global Gastric Cancer Diagnostics Market: Female (2021-2026) & ($ millions)
Figure 14. Global Gastric Cancer Diagnostics Market Size Market Share by Application in 2025
Figure 15. Global Gastric Cancer Diagnostics Revenue Market Share by Player in 2025
Figure 16. Global Gastric Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Figure 17. Americas Gastric Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 18. APAC Gastric Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 19. Europe Gastric Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Gastric Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 21. Americas Gastric Cancer Diagnostics Value Market Share by Country in 2025
Figure 22. United States Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Gastric Cancer Diagnostics Market Size Market Share by Region in 2025
Figure 27. APAC Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 28. APAC Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 29. China Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 33. India Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Gastric Cancer Diagnostics Market Size Market Share by Country in 2025
Figure 36. Europe Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 37. Europe Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 38. Germany Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 39. France Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Gastric Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 52. APAC Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 53. Europe Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 55. United States Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. Canada Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. Mexico Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Brazil Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. China Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Japan Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. Korea Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. India Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Australia Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. Germany Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. France Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. UK Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. Italy Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. Russia Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. Egypt Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. South Africa Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Israel Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. Turkey Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Global Gastric Cancer Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Gastric Cancer Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 1. Gastric Cancer Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastric Cancer Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Gastric Cancer Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Gastric Cancer Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Gastric Cancer Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Gastric Cancer Diagnostics Market Size Market Share by Type in 2025
Figure 10. Gastric Cancer Diagnostics in Male
Figure 11. Global Gastric Cancer Diagnostics Market: Male (2021-2026) & ($ millions)
Figure 12. Gastric Cancer Diagnostics in Female
Figure 13. Global Gastric Cancer Diagnostics Market: Female (2021-2026) & ($ millions)
Figure 14. Global Gastric Cancer Diagnostics Market Size Market Share by Application in 2025
Figure 15. Global Gastric Cancer Diagnostics Revenue Market Share by Player in 2025
Figure 16. Global Gastric Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Figure 17. Americas Gastric Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 18. APAC Gastric Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 19. Europe Gastric Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Gastric Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 21. Americas Gastric Cancer Diagnostics Value Market Share by Country in 2025
Figure 22. United States Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Gastric Cancer Diagnostics Market Size Market Share by Region in 2025
Figure 27. APAC Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 28. APAC Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 29. China Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 33. India Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Gastric Cancer Diagnostics Market Size Market Share by Country in 2025
Figure 36. Europe Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 37. Europe Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 38. Germany Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 39. France Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Gastric Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Gastric Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Gastric Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Gastric Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 52. APAC Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 53. Europe Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 55. United States Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. Canada Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. Mexico Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Brazil Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. China Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Japan Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. Korea Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. India Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Australia Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. Germany Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. France Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. UK Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. Italy Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. Russia Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. Egypt Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. South Africa Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Israel Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. Turkey Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Global Gastric Cancer Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Gastric Cancer Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Gastric Cancer Diagnostics Market Size 2027-2032 ($ millions)
